Informazioni
Non ci sono recensioni
Punto di Riferimento
per Medici e Operatori Sanitari
per Medici e Operatori Sanitari
LIBRERIA STUDIUM
Lipoproteins in Diabetes Mellitus 2nd edition
Jenkins, Toth
Editore
Springer
Anno
2023
Pagine
926
ISBN
9783031266805
200,00 €
DA SCONTARE
Diabetes mellitus has become epidemic on a global scale, and millions of new cases are diagnosed every year. With an estimated 80% of people with diabetes living in disadvantaged regions, and the key roles of lipoproteins in the pathogenesis of the chronic complications of diabetes, this volume will be relevant to many readers globally. It is our intention that the contents will advance knowledge of the readers who will use it to contribute to the reduction of the burden associated with altered lipoproteins in people with diabetes.
The second edition of this book provides an updated and comprehensive review of the field. The book, which includes many tables and figures, is presented in three main sections: (i) Lipoprotein metabolism, qualitative changes and measurements; (ii) Lipoproteins and the complications of diabetes; and (iii) the treatment of lipoproteins in diabetes. Each chapter from the first edition has been updated, and new topics added. New topics include the links between glycemia and lipoproteins, the role of lipoproteins in ischemic stroke, the diagnosis and management of statin intolerance (which is thought to be more common in people with diabetes) and the use of PCSK9 inhibitors and fish oils in the management of lipoproteins in people with diabetes. This book is written by an international group of experts in the clinical, laboratory and research aspects of lipoproteins in diabetes.
Lipoproteins in Diabetes Mellitus, 2nd Edition is a comprehensive reference on the clinical and scientific aspects of lipoproteins in diabetes. It is a must-have resource for primary care and specialist clinicians, clinical and basic science researchers and to trainees and students.
-
Front Matter
Pages i-xx
-
Lipoprotein Metabolism, Qualitative Changes and Measurements
-
Front Matter
Pages 1-1
-
Laboratory Assessment of Lipoproteins in Type 2 Diabetes
- David R. Sullivan
Pages 3-15
-
Tools for Assessing Lipoprotein Metabolism in Diabetes Mellitus
- Richard L. Klein, Andrea J. Semler, Alicia J. Jenkins
Pages 17-31
-
Links Between Glucose and Lipoproteins
- Alicia J. Jenkins
Pages 33-54
-
- Thomas D. Dayspring, Peter P. Toth
Pages 55-109
-
Lipoprotein Metabolism and Alterations Induced by Insulin Resistance and Diabetes
- Gerald H. Tomkin, Daphne Owens
Pages 111-143
-
- Jean Claude Ansquer
Pages 145-167
-
Production and Metabolism of Triglyceride-Rich Lipoproteins: Impact of Diabetes
- Angela Pirillo, Giuseppe D. Norata, Alberico L. Catapano
Pages 169-194
-
- Benjamin Nilsson Wadström, Anders Berg Wulff, Kasper Mønsted Pedersen, Børge Grønne Nordestgaard
Pages 195-222
-
- Anna Gluba-Brzózka, Magdalena Rysz-Górzyńska, Jacek Rysz
Pages 223-245
-
Lipoprotein(a): Metabolism, Pathophysiology, and Impact on Diabetes Mellitus
- Karam Kostner, Gerhard M. Kostner
Pages 247-274
-
Lipoprotein Glycation in Diabetes Mellitus
- Alicia J. Jenkins, Richard L. Klein, Andrea J. Semler, Andrzej S. Januszewski
Pages 275-318
-
Lipid: Extracellular Matrix Interactions as Therapeutic Targets in the Atherosclerosis of Diabetes
- Danielle Kamato, Peter J. Little
Pages 319-336
-
-
Lipoproteins and the Complications of Diabetes
-
Front Matter
Pages 337-337
-
- Maria F. Lopes-Virella, Gabriel Virella
Pages 339-355
-
Endothelial Dysfunction in Type 2 Diabetes with an Update on New Interventions
- Natalie C. Ward, Wann Jia Loh, Gerald F. Watts
Pages 357-406
-
Lipoproteins and Diabetic Kidney Disease
- Fanny Jansson Sigfrids, Nina Elonen, Per-Henrik Groop
Pages 407-438
-
Lipids and Diabetic Retinopathy
- Alicia J. Jenkins
Pages 439-464
-
Roles of Extravasated and Modified Plasma Lipoproteins in Diabetic Retinopathy
- Timothy J. Lyons
Pages 465-484
-
-
The Role of Lipids and Lipoproteins in Peripheral Neuropathy
- Juan D. Collazos-Alemán, María P. Salazar-Ocampo, Carlos O. Mendivil
Pages 485-502
-
Lipoproteins and Ischemic Stroke in Diabetes
- Renato Quispe, Michael Goestch, Brigitte Kazzi, Fawzi Zghyer, Arielle Abovich, Steven Zeiler et al.
Pages 503-522
-
-
Lipoprotein Treatment in Diabetes
-
Front Matter
Pages 523-523
-
About Randomized Clinical Trials Related to Lipoproteins in Diabetes Mellitus
- Anthony Keech, Alicia J. Jenkins, Val Gebski, Ian Marschner
Pages 525-553
-
- Peter Clifton
Pages 555-577
-
Statin Therapy: Impact on Dyslipidemia and Cardiovascular Events in Patients with Diabetes
- Brent M. Gudenkauf, Steven R. Jones, Seth S. Martin
Pages 579-595
-
Statin Intolerance: An Overview for Clinicians
- Stanisław Surma, Joanna Lewek, Peter E. Penson, Maciej Banach
Pages 597-635
-
- Eliot A. Brinton, Vishnu Priya Pulipati
Pages 637-679
-
- Om P. Ganda, Robert Busch, J. R. Nelson, Sephy Philip
Pages 681-704
-
- Harold Edward Bays
Pages 705-734
-
- Peter P. Toth, Manfredi Rizzo, Maciej Banach
Pages 735-753
-
Clinical Care of Lipids in People with Type 1 Diabetes
- Nick S. R. Lan, Alicia J. Jenkins, P. Gerry Fegan
Pages 755-778
-
Adjunct Drug Treatment to Reduce Vascular Disease in People with Diabetes
- Alicia J. Jenkins
Pages 779-819
-
Emerging Lipoprotein-Related Therapeutics for Patients with Diabetes
- Alex Bobik, Neale Cohen, Alicia J. Jenkins, Tin Kyaw, David Sullivan, Xiaoqian Wu et al.
Pages 821-878
-
-
Epidemiology of Diabetes and Diabetic Dyslipidemia
-
Front Matter
Pages 879-879
-
Diabetes Epidemiology and Its Implications
- Zachary Bloomgarden, Yehuda Handelsman
Pages 881-890
-
Epidemiology, Control, and Cardiovascular Outcomes of Dyslipidemia in Diabetes
- Wenjun Fan, Nathan D. Wong
Pages 891-913
-
-
Back Matter
Pages 915-926
-
